Search

Author/Creator Bonacci, M.

1. Anti‐viral therapy can be delayed or avoided in a significant proportion of HBeAg‐negative Caucasian patients in the Grey Zone. Issue 10 (25th March 2018)

Authors:
Bonacci, M.; Lens, S.; Mariño, Z.; Londoño, M.‐C.; Rodríguez‐Tajes, S.; Mas, A.; García‐López, M.; Pérez‐del‐Pulgar, S.; Sánchez‐Tapias, J. M.; Forns, X.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 10(2018)
Page Start:
1397
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti‐viral therapy with an interferon‐free regimen. Issue 8 (16th February 2017)

Authors:
Londoño, M.‐C.; Lens, S.; Mariño, Z.; Bonacci, M.; Ariza, X.; Broquetas, T.; Pla, A.; Bartres, C.; Adriani, M. V.; Rodríguez‐Tajes, S.; Costa, J.; Carrión, J. A.; Pérez‐del‐Pulgar, S.; Forns, X.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 45:Issue 8(2017)
Page Start:
1156
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search